Stock Market Trading Analysis - Stock Market Trading Education - Options Trading - Stock Market Analysis - Research & Stock Market Commentary

CMRX Archive

Chimerix, Inc. (CMRX) live stock market trading education videos on the new ebola drug company.


About Chimerix, Inc., is a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. Its lead compounds include brincidofovir (CMX001), which is in Phase III clinical development; CMX157, a nucleotide analog that has completed Phase I study for the treatment of HIV infections. The company’s proprietary lipid technology and chemical library is under discovery and preclinical stage of development. It has collaboration and license agreement with Merck Sharp & Dohme Corp. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.

<< 1 >>
StockMarketFunding.com on YouTubeStockMarketFunding.com on FacebookStockMarketFunding.com on Google+StockMarketFunding.com on LinkedinStockMarketFunding.com on TwitterImage Map
High Frequency Trading Courses
Market Maker School Sign Up
Ultra High Frequency Trading Platform